48 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
, distribution, marketing, labeling, promotion, sale, price reporting, reimbursement, storage, import, export or disposal of any product manufactured … Substances Act; (vi) any laws or regulations that govern participation in or coverage or reimbursement from any U.S. or state health care program, including
8-K
EX-3.1
b92k nbu6ts7y5zx2c
11 May 23
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-1.1
bir4r0bn1 xsj8xh8
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm